Cybin (CYBN) News Today $0.29 0.00 (0.00%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipShort InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 17, 2024 | americanbankingnews.comCybin Inc. (NYSEAMERICAN:CYBN) Sees Significant Decline in Short InterestJuly 3, 2024 | marketbeat.comCybin Inc. (NYSEAMERICAN:CYBN) Sees Significant Drop in Short InterestCybin Inc. (NYSEAMERICAN:CYBN - Get Free Report) was the recipient of a significant decrease in short interest during the month of June. As of June 15th, there was short interest totalling 20,550,000 shares, a decrease of 10.6% from the May 31st total of 22,990,000 shares. Based on an average daily volume of 4,040,000 shares, the short-interest ratio is presently 5.1 days. Currently, 3.0% of the company's stock are sold short.April 5, 2024 | theglobeandmail.comLSD, Ecstasy, magic mushrooms coming to a clinic near you? Legalization nears for psychedelicsApril 1, 2024 | msn.comInside George Soros’ Portfolio: His Top 8 Stock PicksApril 1, 2024 | msn.com10 Best Stocks To Buy Under $1March 31, 2024 | msn.comFan invades the pitch smoking marijuana and sniffing glue in BrazilMarch 30, 2024 | msn.comPsychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And MoreMarch 20, 2024 | msn.comPsyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And MoreMarch 15, 2024 | msn.comCybin initiates Phase 2 study for psychedelic drug DMTMarch 13, 2024 | msn.comFDA Grants Cybin Breakthrough Therapy Status For Major Depression Psilocybin Therapy, Company Announces Positive Clinical Data & Canadian $150M Private PlacementMarch 13, 2024 | msn.comCybin spikes after FDA breakthrough tag for psychedelic therapyMarch 13, 2024 | finance.yahoo.comAnnounces Oversubscribed Private Placement of U.S. $150 MillionMarch 1, 2024 | marketbeat.comFY2024 EPS Estimates for Cybin Inc. Lowered by Cantor Fitzgerald (NYSEAMERICAN:CYBN)Cybin Inc. (NYSEAMERICAN:CYBN - Free Report) - Investment analysts at Cantor Fitzgerald reduced their FY2024 earnings per share (EPS) estimates for shares of Cybin in a note issued to investors on Tuesday, February 27th. Cantor Fitzgerald analyst C. Duncan now expects that the company will post eFebruary 27, 2024 | finance.yahoo.comCybin to Present at the TD Cowen 44th Annual Health Care ConferenceFebruary 22, 2024 | benzinga.comCybin Stock (AMEX:CYBN) Earnings Dates and Earning CallsFebruary 17, 2024 | finance.yahoo.comALPN Mar 2024 25.000 callFebruary 16, 2024 | benzinga.comCybin Inc. Q3 Earnings: Clinical Advances Amid Financial LossJanuary 9, 2024 | msn.comCybin Inc's Two Deuterated Psychedelic Molecules Achieve Positive Topline Clinical ResultsJanuary 4, 2024 | finance.yahoo.comCybin Highlights Recent Topline Results and Outlines Key Upcoming Milestones Across its Clinical Development ProgramsDecember 5, 2023 | finance.yahoo.comCybin Announces Four Poster Presentations at the 2023 American College of Neuropsychopharmacology Annual Meeting Including CYB003 Phase 2 Topline ResultsNovember 16, 2023 | finance.yahoo.comCybin to Release Phase 2 Topline Safety and Efficacy Data for CYB003 in Major Depressive Disorder and Host R&D Briefing on November 30, 2023November 15, 2023 | finance.yahoo.comCybin Announces Poster Presentation at Neuroscience 2023 Annual MeetingNovember 14, 2023 | benzinga.comThinking about buying stock in Hanryu Holdings, Absci Corp, Spero Therapeutics, BioXcel Therapeutics, or Cybin?October 31, 2023 | finance.yahoo.comCybin Announces Unprecedented Positive Phase 2 Interim Data for CYB003 in Major Depressive Disorder Meeting Primary Efficacy Endpoint with Rapid and Significant Improvements in Depression Symptoms After Single DoseOctober 31, 2023 | finance.yahoo.comCybin Announces Unprecedented Positive Interim Phase 2 Data for CYB003 in Major Depressive Disorder Meeting Primary Efficacy Endpoint with Rapid and Significant Improvements in Depression Symptoms After Single Dose - Full Topline Data on Track for Q4 2023October 25, 2023 | finance.yahoo.comCybin Announces Grant of Two New United States Patents Protecting its Deuterated DMT ProgramOctober 23, 2023 | msn.comPsychedelic drug developer Cybin completes acquisition of Small PharmaOctober 23, 2023 | finance.yahoo.comCybin Completes Acquisition of Small Pharma Inc. to Create International Clinical-stage Leader in Novel Psychedelic TherapeuticsOctober 13, 2023 | benzinga.comCybin And Small Pharma Shareholders Green Light Acquisition Resolution: Results & Expected DatesOctober 3, 2023 | benzinga.comSteve Cohen Keeps Betting On Biopharma With Purchase Of 119M+ Bionomics SharesSeptember 21, 2023 | finance.yahoo.comCybin Completes Enrollment in Phase 2 Study of CYB003 in Major Depressive DisorderAugust 31, 2023 | msn.comPsilocybin in depression: Study shows lasting benefitAugust 28, 2023 | finance.yahoo.comCanadian Investment Regulatory Organization Trade Resumption - CYBNAugust 28, 2023 | finance.yahoo.comCanadian Investment Regulatory Organization Trading Halt - CYBN Get Cybin News Delivered to You Automatically Sign up to receive the latest news and ratings for CYBN and its competitors with MarketBeat's FREE daily newsletter. Email Address Man Who Called Nvidia at $1.10 Says Buy This Now... (Ad)In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new company could become the next to soar like Nvidia. Watch Alex's "Next Magnificent Seven" presentation now. CYBN Media Mentions By Week CYBN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CYBN News Sentiment▼0.000.62▲Average Medical News Sentiment CYBN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CYBN Articles This Week▼00▲CYBN Articles Average Week Get Cybin News Delivered to You Automatically Sign up to receive the latest news and ratings for CYBN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: NGENF News Today LIAN News Today PHGE News Today IBIO News Today BRTX News Today PHXM News Today NBY News Today KLDO News Today AGNPF News Today AKBLF News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:CYBN) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredThe asset beating inflation by 4xCentral Bank Gold Heist In Progress Central banks are buying gold at record rates... and billionaire invest...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cybin Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cybin With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CYBN Stock Alerts